Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Dunad Therapeutics and 2692372 Ontario, Inc. patent compounds for cancer

June 17, 2021

Janssen Pharmaceutica presents new Mcl-1 inhibitors

June 17, 2021

SpringWorks initiates phase I/II study of mirdametinib in children and young adults with LGG

June 17, 2021

ORIN-1001 shows promising preliminary antitumor activity in heavily pretreated solid tumors

June 16, 2021

First-in-human data for FLT3 inhibitor FF-10101

June 16, 2021

Linnaeus and Merck & Co. expand collaborative evaluation of LNS-8801 with Keytruda

June 16, 2021

Investigator-initiated study of Salarius' seclidemstat in hematologic cancers begins

June 16, 2021

Medshine Discovery discloses ROS1 inhibitors

June 16, 2021

FDA clears IND for lisaftoclax for ER-positive breast cancer and other solid tumors

June 15, 2021

G1 Therapeutics initiates phase II trial of Cosela in metastatic bladder cancer

June 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...